18 Results for "

ERAP1

" in MedChemExpress (MCE) Product Catalog:
Products (18)

18 Results for "ERAP1" in MCE Product Catalog:

5
5 Cited Publications
Cat. No.: HY-133125
CAS No.: 865273-97-8
Purity:  98.77%
Target:  

Aminopeptidase

Research Areas:  

Inflammation/Immunology

ERAP1-IN-1 is an endoplasmic reticulum aminopeptidase 1 (ERAP1) inhibitor. ERAP1-IN-1 competitively inhibits ERAP1 activity towards a nonamer peptide representative of physiological substrates [1].
loading...
    loading...
Cat. No.: HY-169915
CAS No.: 2643320-62-9
Target:  

Aminopeptidase

Research Areas:  

Inflammation/Immunology Cancer

ERAP1 modulator-2 (compound 10) is a potent ERAP1 inhibitor with an IC50 value of <100 nM [1].
loading...
    loading...
Cat. No.: HY-139907B
Purity:  99.60%
Target:  

Aminopeptidase

Research Areas:  

Inflammation/Immunology Cancer

DG013A (formate) is a phosphinic acid tripeptide mimetic inhibitor. DG013A (formate) displays significantly weak affinity for both ERAP1 (IC50=33 nM) and ERAP2 (IC50=11 nM). DG013A (formate) can be used for the research of autoimmune disease and cancer [1].
loading...
    loading...
Cat. No.: HY-169913
CAS No.: 2766036-51-3
Target:  

Aminopeptidase

Research Areas:  

Inflammation/Immunology Cancer

ERAP1 modulator-1 (Compound 1) is the modulator for endoplasmic reticulum aminopeptidase 1 (ERAP1) with IC50 < 250 nM [1].
loading...
    loading...
Cat. No.: HY-RS04463
Research Areas:  

Others

ERAP1 Human Pre-designed siRNA Set A contains three designed siRNAs for ERAP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS17658
Research Areas:  

Others

Erap1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Erap1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-139907
CAS No.: 2007955-07-7
Target:  

Aminopeptidase

Research Areas:  

Inflammation/Immunology Cancer

DG013A is a phosphinic acid tripeptide mimetic inhibitor. DG013A displays significantly weak affinity for both ERAP1 (IC50=33 nM) and ERAP2 (IC50=11 nM). DG013A can be used for the research of autoimmune disease and cancer [1].
loading...
    loading...
Cat. No.: HY-RS24119
Research Areas:  

Others

Erap1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Erap1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-168181
Target:  

Aminopeptidase

Research Areas:  

Others

ERAP1-IN-2 (compound 3f) is an inhibitor of ERAP1 (endoplasmic reticulum aminopeptidase 1). ERAP1-IN-2 has an IC50 value of 1.72 μM against hERAP1 [1].
loading...
    loading...
Cat. No.: HY-169936
Target:  

Aminopeptidase

Research Areas:  

Inflammation/Immunology Cancer

ERAP1-IN-3 (compound 13) is a potent endoplasmic reticulum aminopeptidase 1 (ERAP1) inhibitor, with a pIC50 of 8.6. ERAP1-IN-3 has potential for the research of cancer immunotherapy and autoimmune disease [1].
loading...
    loading...
Cat. No.: HY-183267
Target:  

Aminopeptidase

Research Areas:  

Cancer

ERAP1-IN-4 is an orally acvtive endoplasmic reticulum aminopeptidase 1 (ERAP1) inhibitor with a pIC50 of 7.9 and an LLE of 5.3. ERAP1-IN-4 inhibits hydrolysis of peptide substrates by ERAP1, with high activity against Allotype1 and Allotype2. ERAP1-IN-4 reduced efficacy against other allotypes, and modulates ERAP1-mediated peptide processing to inhibit antigenic epitope presentation. ERAP1-IN-4 can be used for the research of cancer[1].
loading...
    loading...
Cat. No.: HY-139907A
CAS No.: 2758817-06-8
Target:  

Aminopeptidase

Research Areas:  

Others

DG013B is an epimer of DG013A (HY-139907). DG013B has weak affinity for ERAP1 and ERAP2 and is often used as a negative control to study the binding properties of DG013A and its analogues to ERAP1 and ERAP2 [1].
loading...
    loading...
Cat. No.: HY-139907C
Purity:  99.57%
Target:  

Aminopeptidase

Research Areas:  

Others

DG013B formate is an epimer of DG013A (HY-139907). DG013B formate has weak affinity for ERAP1 and ERAP2 and is often used as a negative control to study the binding properties of DG013A and its analogues to ERAP1 and ERAP2 [1].
loading...
    loading...
Cat. No.: HY-173022
Target:  

Aminopeptidase

Research Areas:  

Others

BDM_92499 is a nanomolar selective IRAP inhibitor, with an IC50 of 3.4 nM. BDM_92499 also inhibits ERAP1 and ERAP2, with IC50 values of 0.46 μM and 4.2 μM, respectively [1].
loading...
    loading...
Cat. No.: HY-179625
Target:  

Aminopeptidase

Research Areas:  

Inflammation/Immunology Cancer

GSK235 is an orally active, selective and allosteric endoplasmic reticulum aminopeptidase 1 (ERAP1) inhibitor with pIC50 values of 8.45 and 7.59 for human and mouse ERAP1, respectively. GSK235 exhibits over 1000-fold selectivity for the two most homologous enzymes, ERAP2 and IRAP. GSK235 can regulate the immunopeptidome of cancer cells and enhance cancer cell antigenicity. GSK235 can be used for the study of colorectal cancer and arthritis [1].
loading...
    loading...
Cat. No.: HY-P82414
Synonyms: ERAP1; APPILS; ARTS1; KIAA0525; Endoplasmic reticulum aminopeptidase 1; ARTS-1; Adipocyte-derived leucine aminopeptidase; A-LAP; Aminopeptidase PILS; Puromycin-insensitive leucyl-specific aminopeptidase; PILS-AP; Type 1 tumor necrosis facto

Host:  

Rabbit

Application:  

WB, IHC-P

Reactivity:  

Human, Rat

loading...
    loading...
Cat. No.: HY-P82414A
Synonyms: ERAP1; APPILS; ARTS1; KIAA0525; Endoplasmic reticulum aminopeptidase 1; ARTS-1; Adipocyte-derived leucine aminopeptidase; A-LAP; Aminopeptidase PILS; Puromycin-insensitive leucyl-specific aminopeptidase; PILS-AP; Type 1 tumor necrosis facto

Host:  

Rabbit

Application:  

WB, IHC-P

Reactivity:  

Human, Rat

loading...
    loading...
Cat. No.: HY-184499
CAS No.: 2420554-24-9
Target:  

MHC Aminopeptidase

Research Areas:  

Cancer

GRWD5769 is an orally potent ERAP1 inhibitor. GRWD5769 regulates the peptide repertoire presented by MHC-I, alters TCR diversity/clonality, reprograms antigen-experienced T cells, induces novel T cell responses, drives tumor cell killing, and alleviates T cell exhaustion. GRWD5769 can be used in the research of advanced solid malignancies, microsatellite-stable colorectal cancer, non-small cell lung cancer, bladder cancer, hepatocellular carcinoma, head and neck squamous cell carcinoma, and cervical cancer [1] .
loading...
    loading...
  • 1